Q3 FY2026 · ended Sep 30, 2026 · Revenue $203.00M, +41.1% YoY · Filed Nov 5, 2026
TransMedics Group, Inc. (TMDX) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $203.0 million and net income of $17.1 million. Free cash flow was $27.6 million. As of Sep 30, 2026 it held $493.0 million in cash and investments and $411.9 million in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- TMDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Andover, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1756262
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $203.0M | $189.9M | $173.9M | $160.8M | $143.8M |
| Operating income | $28.1M | $23.7M | $13.3M | $21.3M | $23.3M |
| Net income | $17.1M | $14.7M | $7.3M | $105.4M | $24.3M |
| Diluted EPS | $0.46 | $0.41 | $0.20 | $2.57 | $0.66 |
| Operating cash flow | $36.0M | $17.3M | $24.5M | $34.5M | $69.6M |
| Free cash flow | $27.6M | $10.2M | -$12.1M | $19.0M | $61.9M |
| Total assets | $1.5B | $1.5B | $1.4B | $1.1B | $946.0M |
| Total liabilities | $967.2M | $946.3M | $940.8M | $595.3M | $590.8M |
| Stockholders' equity | $550.7M | $518.1M | $494.0M | $473.1M | $355.2M |
| Cash and investments | $493.0M | $472.7M | $461.7M | $488.4M | $466.2M |
| Total debt | $411.9M | $373.7M | $365.2M | $16.9M | $12.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 10, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
All 628 TransMedics Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.